Startup India Government of India
Rynn Pharmaceuticals Private Limited
Rynn Pharmaceuticals Private Limited - healthcare in Ghaziabad, Uttar Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2024
₹11.21 Lakh
▼ 39% YoY
Net loss · FY 2024
₹68,211
Net margin -6.1%
EBITDA · FY 2024
-₹47,058
EBITDA margin -4.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Rynn Pharmaceuticals Private Limited
Data last updated:
Rynn Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 13 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33100UP2020PTC130851.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nidhi Singh and Neeraj Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No – Cp 01/B Shop No – 125/126 Govindpuram, Ghaziabad, Uttar Pradesh, India – 201013.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.21 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹68,211 (net margin -6.1%) and EBITDA of -₹47,058 (EBITDA margin -4.2%). Revenue has declined at a compounded annual rate (CAGR) of 51% over three years.
Rynn Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0000533).
Company details
CIN U33100UP2020PTC130851
Registration Number 130851
Incorporation Date 13 July 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0000533
Recognitions & Rankings of Rynn Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UP-29-0000533
Contact details
Rynn Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressP.No – Cp 01/B Shop No – 125/126 Govindpuram, Ghaziabad, Uttar Pradesh, India – 201013
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
Comprehensive company report
Rynn Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rynn Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rynn Pharmaceuticals Private Limited, buy the company report.
Financials of Rynn Pharmaceuticals Private Limited
FY 2025 filings availableRynn Pharmaceuticals Private Limited reported revenue of ₹11.21 Lakh (down 39% YoY) for FY 2024.
Revenue · FY 2024
₹11.21 Lakh ▼ 39%
Net loss · FY 2024
₹68,211 margin -6.1%
EBITDA · FY 2024
-₹47,058 margin -4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 51%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▼ 45%
Revenue has declined at a compounded annual rate (CAGR) of 51% over three years, including a 39% fall in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹47,058 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹68,211 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -4.2% | |||
| Net Profit Margin | -6.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rynn Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rynn Pharmaceuticals Private Limited
Rynn Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Singh | Additional Director | 24 Jun 2022 | 4 Years 4 Months | Current |
| Nidhi Singh | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Rynn Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A C Pharmaceuticals Pvt Ltd | ₹11.26 Lakh (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Delbert Pharmaceuticals Private Limited | ₹11.25 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Brugen Pharmaceuticals Private Limited | ₹11.23 Lakh (FY 2025) | 88.0% | Jabalpur, Madhya Pradesh, India | |||
| Panmed Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2017) | -49.0% | Chennai, Tamil Nadu, India | |||
| Rynn Pharmaceuticals Private Limitedthis company | ₹11.21 Lakh (FY 2024) | -₹68,211 | -6.1% | -39.0% | Ghaziabad, Uttar Pradesh, India | |
| Fronde Pharmaceuticals Private Limited | ₹11.2 Lakh (FY 2025) | -8.0% | Cuttack, Odisha, India | |||
| Altmann Pharmaceuticals Private Limited | ₹11.17 Lakh (FY 2025) | 30.0% | Karnal, Haryana, India | |||
| Specura Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2025) | 48.0% | Pune, Maharashtra, India | |||
| Lifecord Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2019) | 132.0% | Ghaziabad, Uttar Pradesh, India | |||
| Lion in Pharmaceuticals India Private Limited | ₹11.13 Lakh (FY 2025) | -22.0% | Yelahanka, Karnataka, India |
To see the full peer comparison of Rynn Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rynn Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rynn Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rynn Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rynn Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Shikha Manhas ceased to be Director on 25 Jun 2022.
AGM
Rynn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rynn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Shikha Manhas ceased to be Director.
Appointed
Neeraj Singh was appointed as Additional Director.
Appointed
Nidhi Singh was appointed as Director.
Incorporation
13 Jul 2020
Rynn Pharmaceuticals Private Limited was registered on 13 Jul 2020 with Roc Uttar Pradesh Ii & aged 6 years 3 months as per MCA records.
Frequently asked questions
Rynn Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 13 July 2020 (6+ years old) and is registered under CIN U33100UP2020PTC130851.
Rynn Pharmaceuticals has 2 current directors:
- Neeraj Singh - Additional Director
- Nidhi Singh - Director
The latest financial statements of Rynn Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Rynn Pharmaceuticals is U33100UP2020PTC130851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rynn Pharmaceuticals was incorporated on 13 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Rynn Pharmaceuticals by revenue are A C Pharmaceuticals Pvt Ltd, Delbert Pharmaceuticals Private Limited, Brugen Pharmaceuticals Private Limited, Panmed Pharmaceuticals Private Limited, Fronde Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shikha Manhas ceased to be Director on 25 Jun 2022. Neeraj Singh was appointed as Additional Director on 24 Jun 2022. Nidhi Singh was appointed as Director on 13 Jul 2020.
Yes, Rynn Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rynn Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0000533).
The registered office of Rynn Pharmaceuticals is at P.No – Cp 01B Shop No – 125126 Govindpuram, Ghaziabad, Uttar Pradesh, India – 201013.
Rynn Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.